Home / Inspections / 965123

FDA Inspection 965123 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 1825662

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on January 28, 2016 in Mount Vernon, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 28, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mount Vernon, IN (United States)

Facility

Other inspections at this facility

  • 1218331 (VAI Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 853863 (VAI Fri Oct 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 798609 (NAI Thu Sep 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 751470 (VAI Fri Oct 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 741276 (NAI Fri Aug 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources